Central and regional hemodynamic effects of flosequinan for congestive heart failure
- 1 June 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (18), 1354-1359
- https://doi.org/10.1016/0002-9149(89)91048-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind menJournal of the American College of Cardiology, 1987
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987
- Hemodynamic changes after meals and placebo treatment in chronic congestive heart failureThe American Journal of Cardiology, 1986
- Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.Circulation, 1985
- Nifedipine in congestive heart failure: Effects on resting and exercise hemodynamics and regional blood flowAmerican Heart Journal, 1984
- Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.Circulation, 1984
- The Effect of Vasodilator Therapy on Systolic and Diastolic Time Intervals in Congestive Heart FailureChest, 1982
- Prazosin and Hydralazine in Congestive Heart FailureAnnals of Internal Medicine, 1981
- Positive inotropic effects of hydralazine in human subjects: Comparison with prazosin in the setting of congestive heart failureThe American Journal of Cardiology, 1980
- Hepatic vascular bed.Physiological Reviews, 1971